Bayer Leverkusen chief confirms Boniface won’t join Al Nassr
The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...
Bayer Leverkusen have announced that they have completed the signing of Mario Hermoso on a six-month loan from Serie A side ...
An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Bayer pleaded with Missouri lawmakers Thursday to pass legislation critics say would shield the company from lawsuits claiming its glyphosate-based herbicide Roundup causes cancer. Representatives for ...
Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...
Following the successful completion of his scheduled medical, Argentina international Emiliano Buendia was officially ...
After becoming a first-team mainstay in his first two seasons at the club, Buendía spent the 2023/24 campaign on the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch of one of the ...
Spanish center Mario Hermoso embarks on a new adventure in his career after a brief stint with AS Roma. The 29-year-old ...
Bayern Munich took a small but potentially decisive step toward the Bundesliga title last weekend when defending champion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback